Biotechnology, pharmaceutical, diagnostic and medical device companies at various stages often encounter potential antitrust issues arising from brand-generic competition, patent litigation and settlements, life cycle management strategies, sales practices, M&A, and other transformative transactions including licensing and competitor collaborations. In this webinar, lawyers from WilmerHale’s leading Life Sciences Practice will provide an overview of antitrust principles followed by an in-depth discussion on industry developments and considerations for in-house counsel and executives navigating these risks.
*CLE credit is not available for those who watch webinar recordings.
